Follow
Nete Tofte
Nete Tofte
Steno Diabetes Center Copenhagen
Verified email at regionh.dk
Title
Cited by
Cited by
Year
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational …
N Tofte, M Lindhardt, K Adamova, SJL Bakker, J Beige, JWJ Beulens, ...
The lancet Diabetes & endocrinology 8 (4), 301-312, 2020
1852020
Utility of plasma concentration of trimethylamine N-oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes
SA Winther, JC Øllgaard, N Tofte, L Tarnow, Z Wang, TS Ahluwalia, ...
Diabetes care 42 (8), 1512-1520, 2019
962019
Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes
N Tofte, T Suvitaival, L Ahonen, SA Winther, S Theilade, M Frimodt-Møller, ...
Scientific reports 9 (1), 16398, 2019
682019
Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes
S Pilemann-Lyberg, TW Hansen, N Tofte, SA Winther, S Theilade, ...
Diabetes Care 42 (6), 1088-1094, 2019
662019
Metabolomic assessment reveals alteration in polyols and branched chain amino acids associated with present and future renal impairment in a discovery cohort of 637 persons …
N Tofte, T Suvitaival, K Trost, IM Mattila, S Theilade, SA Winther, ...
Frontiers in endocrinology 10, 818, 2019
442019
Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients
N Tofte, C Jensen, M Tvede, CB Andersen, J Carlsen, M Iversen
Scandinavian journal of infectious diseases 44 (11), 835-841, 2012
402012
Soluble urokinase plasminogen activator receptor predicts cardiovascular events, kidney function decline, and mortality in patients with type 1 diabetes
V Rotbain Curovic, S Theilade, SA Winther, N Tofte, J Eugen-Olsen, ...
Diabetes care 42 (6), 1112-1119, 2019
352019
Markers of collagen formation and degradation reflect renal function and predict adverse outcomes in patients with type 1 diabetes
S Pilemann-Lyberg, DGK Rasmussen, TW Hansen, N Tofte, SA Winther, ...
Diabetes Care 42 (9), 1760-1768, 2019
342019
Characteristics of high‐and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in …
N Tofte, M Lindhardt, K Adamova, J Beige, JWJ Beulens, AL Birkenfeld, ...
Diabetic Medicine 35 (10), 1375-1382, 2018
282018
Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus
NH Tougaard, S Theilade, SA Winther, N Tofte, TS Ahluwalia, TW Hansen, ...
Journal of the American Heart Association 9 (19), e017165, 2020
272020
Plasma metabolomics identifies markers of impaired renal function: a meta-analysis of 3089 persons with type 2 diabetes
N Tofte, N Vogelzangs, D Mook-Kanamori, A Brahimaj, J Nano, ...
The Journal of Clinical Endocrinology & Metabolism 105 (7), 2275-2287, 2020
272020
Chronic urinary tract infections in patients with spinal cord lesions–biofilm infection with need for long‐term antibiotic treatment
N Tofte, ACY Nielsen, H Trøstrup, CB Andersen, M Von Linstow, ...
Apmis 125 (4), 385-391, 2017
202017
Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?
N Tofte, F Persson, P Rossing
Journal of nephrology 33, 931-948, 2020
142020
Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes
V Rotbain Curovic, S Theilade, SA Winther, N Tofte, L Tarnow, A Jorsal, ...
Diabetic Medicine 38 (5), e14459, 2021
122021
PRIORITY investigators. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a …
N Tofte, M Lindhardt, K Adamova, SJL Bakker, J Beige, JWJ Beulens, ...
Lancet Diabetes Endocrinol 8 (4), 301-312, 2020
122020
Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes
LF Ferreira-Divino, T Suvitaival, V Rotbain Curovic, N Tofte, K Trošt, ...
Cardiovascular Diabetology 21 (1), 135, 2022
102022
Changes in diabetes distress among people with type 2 diabetes during a risk screening programme for diabetic kidney disease–longitudinal observations of the PRIORITY study
LE Joensen, KP Madsen, M Frimodt-Møller, N Tofte, I Willaing, ...
Journal of diabetes and its complications 34 (1), 107467, 2020
102020
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes
I Khurana, H Kaipananickal, S Maxwell, S Birkelund, A Syreeni, ...
The Journal of Clinical Investigation 133 (4), 2023
82023
Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes
HØ Hjortkjær, F Persson, S Theilade, SA Winther, N Tofte, TS Ahluwalia, ...
Journal of Diabetes and its Complications 36 (9), 108270, 2022
62022
Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
T Bjerre-Christensen, SA Winther, N Tofte, S Theilade, TS Ahluwalia, ...
BMJ Open Diabetes Research and Care 9 (1), e002289, 2021
62021
The system can't perform the operation now. Try again later.
Articles 1–20